Digitalis purpurea nectar within. The fruit is a capsule which splits open at maturity to release the numerous tiny 0.1-0.2 mm seeds. The three subspecies of "Digitalis purpurea" are: Due to the presence of the cardiac glycoside digitoxin, the leaves, flowers and seeds of this plant are all poisonous to humans and some animals and can be fatal if ingested. Extracted from the leaves, this same compound, whose clinical use was pioneered by William Withering, is used as a medication for heart failure. He recognized it "reduced dropsy", increased urine flow and had a powerful effect on the heart. Unlike the purified
Criticism of the Food and Drug Administration licensing fees to drug manufacturers, which has led to enormous increases in generic drug pricing. In 2013 and 2014, generic drug pricing for over 200 drugs increased over 100%. Many of those drugs had price hikes over 1000%. It has been reported that 75% of the FDA generic drug oversight budget comes directly from private drug companies. A historical example of how the FDA seemingly favors the pharmaceutical industry either from clandestine direct money payments to FDA directors and scientific advisers or other undisclosed or unknown means was seen with the generic drug droperidol. Droperidol was a widely used antiemetic